Company: NDRA
Filing Date: 2025-11-06
Form Type: S-3
Source: 0001213900-25-107232
Chunk: 32

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-11-06
Form: S-3
Chunk 32
---
) with any interested stockholder (as defined below) for a period of three years following the date that the stockholder
became an interested stockholder, unless:

| ● | prior                                                                                            
 to that date, the board of directors of the corporation approved either the business combination 
 or the transaction that resulted in the stockholder becoming an interested stockholder;          |

| ● | upon                                                                                                 
 consummation of the transaction that resulted in the stockholder becoming an interested stockholder, 
 the interested stockholder owned at least 85% of the voting stock of the corporation outstanding     
 at the time the transaction commenced, excluding for purposes of determining the number of           
 shares of voting stock outstanding (but not the voting stock owned by the interested stockholder)    
 those shares owned by persons who are directors and officers and by excluding employee stock         
 plans in which employee participants do not have the right to determine confidentially whether       
 shares held subject to the plan will be tendered in a tender or exchange offer; or                   |

| ● | on                                                                                         
 or subsequent to the time the business combination is approved by the board of directors   
 of the corporation and authorized at an annual or special meeting of stockholders, and not 
 by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting  
 stock that is not owned by the interested stockholder.                                     |

In general, Section 203 defines
“business combination” to include the following:

| ● | any                                                                               
 merger or consolidation involving the corporation and the interested stockholder; |

| ● | any                                                                                      
 sale, lease, exchange, mortgage, transfer, pledge or other disposition of 10% or more of 
 the assets of the corporation involving the interested stockholder;                      |

| ● | subject                                                                                            
 to certain exceptions, any transaction that results in the issuance or transfer by the corporation 
 of any stock of the corporation to the interested stockholder;                                     |

| ● | subject                                                                                            
 to limited exceptions, any transaction involving the corporation that has the effect of increasing 
 the proportionate share of the stock of any class or series of the corporation beneficially        
 owned by the interested stockholder; or                                                            |

| ● | the                                                                                      
 receipt by the interested stockholder of the benefit of any loans, advances, guarantees, 
 pledges or other financial benefits provided by or through the corporation.              |

Section 203 generally defines
an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock